However, four articles were excluded due to the unavailability of full-text access, which resulted in missing critical information necessary for inclusion
With ongoing support and healthy habits, many patients sustain their weight loss over the long term
D'Journo XB, Boulate D, Fourdrain A, Loundou A, van Berge Henegouwen MI, Gisbertz SS, O'Neill JR, Hoelscher A, Piessen G, van Lanschot J, Wijnhoven B, Jobe B, Davies A, Schneider PM, Pera M, Nilsson M, Nafteux P, Kitagawa Y, Morse CR, Hofstetter W , Molena D, So JB, Immanuel A, Parsons SL, Larsen MH, Dolan JP, Wood SG, Maynard N, Smithers M, Puig S, Law S, Wong I, Kennedy A, KangNing W, Reynolds JV, Pramesh CS, Ferguson M, Darling G, Schrder W, Bludau M, Underwood T, van Hillegersberg R, Chang A, Cecconello I, Ribeiro U, de Manzoni G, Rosati R, Kuppusamy M, Thomas PA, Low DE, Study Group IE
Genetic testing at $99 (available after the first month of treatment) helps PlexusDx clinicians adjust starting doses, anticipate side-effect risk, and decide whether dual-compound therapies like GLP-Squared (semaglutide + tirzepatide combined) would improve outcomes
This tailored approach is a genuine advantage of compounded formulations
.png)
